2006 Press releases


Displaying 1 - 10 of 11



1 November 2006
Third Quarter Report 2006

Third Quarter Highlights

  • Inclusion in the "first-into-man" study of Clavis Pharma's second cancer drug..

18 September 2006
Clavis Pharma and Mount Sinai School of Medicine have entered into collaboration agreement for the development of new cancer drugs

Clavis Pharma ASA, a public development stage pharmaceutical company focusing on cancer therapeutics, and Mount Sinai School of Medicine (MSSM) ...


15 August 2006
Second quarter report from Clavis Pharma ASA

With funds secured and new key executives in place, Clavis Pharma is expanding its clinical development programme and business development efforts.


7 July 2006
Clavis Pharma ASA listed on the Oslo Stock Exchange today. TICKER CLAVIS

26 June 2006
Clavis Pharma ASA - Equity Offering 26 - 30 June 2006

22 June 2006
Clavis Pharma ASA to be listed on the Oslo Stock Exchange

20 June 2006
Clavis Pharma ASA - Offering well received

15 June 2006
Clavis Pharma ASA-Equity Offering

13 June 2006
Clavis Pharma receives clearance to begin Phase I clinical trial with the novel cancer drug CP-4126

1 June 2006
Clavis Pharma's ELACYT™ Enters Phase I/II Clinical Leukaemia Study